Global Postpartum Depression Market to Hit $66.47 Billion by 2030 at 33.1% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Postpartum Depression Market Expected To Scale Between 2026 And 2030?

The postpartum depression market size has expanded significantly in recent years. It is projected to increase from $16.05 billion in 2025 to $21.17 billion in 2026, achieving a compound annual growth rate (CAGR) of 31.9%. The historical growth of this market can be linked to factors such as a heightened recognition of maternal mental health disorders, inadequate early screening practices, prevalent underdiagnosis within postpartum care environments, a continued reliance on traditional counseling approaches, and the expansion of hospital-based maternal care services.

The postpartum depression market size is anticipated to experience substantial growth over the next few years. It is projected to reach $66.48 billion by 2030, advancing at a compound annual growth rate (CAGR) of 33.1%. This expansion during the forecast period can be linked to the greater adoption of digital screening tools, a heightened focus on preventive maternal healthcare, the broadening of tele-mental health services, an increase in investment for women’s mental health programs, and the enhanced incorporation of mental health into obstetric care. Significant trends expected in the forecast period involve increased awareness and screening for postpartum mental health, the growing acceptance of digital mental health platforms, a stronger emphasis on early diagnosis and intervention, the extension of community-based support programs, and improved integration of mental health services within maternal care.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13024&type=smp

Which Factors Are Influencing The Growth Of The Postpartum Depression Market?

The increasing number of childbirths is projected to boost the growth of the postpartum depression market. Childbirth is defined as the process by which a baby exits the mother’s uterus, typically through the vaginal canal. This rise in births impacts the postpartum depression market as postpartum depression (PPD) is a prevalent mental health condition affecting women after delivery, leading to symptoms like sadness, anxiety, fatigue, and difficulties in bonding with the infant. For instance, in January 2023, a report from the Centers for Disease Control and Prevention, a US-based national public health organization, revealed that the United States experienced a 1% increase in registered births, reaching 3,664,292, compared to the prior year. Thus, the growing number of childbirths is a key factor driving the expansion of the postpartum depression market.

How Is Segmentation Applied In The Postpartum Depression Market Segment Analysis?

The postpartum depression market covered in this report is segmented –

1) By Types: Postpartum Blues, Postpartum Anxiety, Postpartum Obsessive Compulsive Disorder, Postpartum Panic Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Psychosis, Other Types

2) By Treatment: Psychotherapy, Medication, Supplements, Other Treatments

3) By Route of Administration: Oral, Parenteral, Other Route Of Administration

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Postpartum Blues: Mild Emotional Disturbances, Short-term Mood Swings

2) By Postpartum Anxiety: Generalized Anxiety Disorder (GAD), Panic Attacks

3) By Postpartum Obsessive Compulsive Disorder: Intrusive Thoughts, Compulsive Behaviors

4) By Postpartum Panic Disorder: Sudden Panic Attacks, Physical Symptoms

5) By Postpartum Post-Traumatic Stress Disorder (PTSD): Trauma Response To Childbirth, Flashbacks And Anxiety

6) By Postpartum Psychosis: Hallucinations, Severe Mood Swings

7) By Other Types: Mixed Mood Disorders, Comorbid Conditions With Postpartum

Which Trends Are Influencing Demand In The Postpartum Depression Market?

Leading companies operating in the postpartum depression market are concentrating on new product innovations, such as achieving regulatory milestones to improve the development and potential approval pathway for zuranolone, intended for major depressive disorder and postpartum depression. A regulatory milestone denotes a significant event in the lifecycle of a drug or medical product, marking progress within the approval or compliance process set by governmental authorities. For example, in February 2023, Biogen Inc., a US-based biotechnology company, and Sage Therapeutics Inc., a US-based biopharmaceutical company, disclosed that the United States Food and Drug Administration (FDA) had accepted the filing of a new drug application (NDA) for zuranolone to manage major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is an experimental medication being tested as a 14-day, once-daily, rapid-acting oral therapy for individuals with MDD and PPD. This neuroactive steroid functions as a positive allosteric modulator of GABA-A receptors, representing a unique mechanism of action. It is anticipated to work in persons with depression by quickly resetting dysregulated neural networks to help restore brain function, impacting brain networks that control mood, arousal, behavior, and even cognition.

Who Are The Companies Participating In The Postpartum Depression Market Environment?

Major companies operating in the postpartum depression market are Pfizer Inc., Johnson & Johnson, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb Co., AstraZeneca plc, GlaxoSmithKline LLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Biogen Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Mallinckrodt Pharmaceuticals plc, Sage Therapeutics Inc., Otsuka Pharmaceutical Co. Ltd., Lundbeck A S, Janssen Pharmaceuticals, Aurobindo Pharma Ltd.

Get The Full Postpartum Depression Market Report:

https://www.thebusinessresearchcompany.com/report/postpartum-depression-global-market-report

Which Geographic Region Dominates The Postpartum Depression Market?

North America was the largest region in the postpartum depression market in 2025. The regions covered in the postpartum depression market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Postpartum Depression Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/postpartum-depression-global-market-report

Browse Through More Reports Similar to the Global Postpartum Depression Market 2026, By The Business Research Company

Postpartum Health Supplements Market Report 2026

https://www.thebusinessresearchcompany.com/report/postpartum-health-supplements-global-market-report

Wellness Supplements Market Report

https://www.thebusinessresearchcompany.com/report/wellness-supplements-global-market-report

Immune Health Supplements Market Report

https://www.thebusinessresearchcompany.com/report/immune-health-supplements-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795